UltiMed acquired by Indianapolis company, plans expansion
Wednesday, October 22, 2014
For the full story, visit www.desmetnews.com and open the link to our eEdition.
The Indianapolis, Ind., based investment company, LDI, Ltd. has recently acquired UltiMed Inc., a rapidly growing manufacturer and distributor of pen needles, insulin syringes and other injection related products for both humans and pets. UltiMed is headquartered in Minneapolis, Minn., and operates manufacturing facilities in De Smet and South Korea.
The same local management team will remain in place.
Since 1912, the Lacy family of Indianapolis has owned LDI, LTD. The company specializes in acquiring profitable established companies with long-term growth potential and making additional investments to help facilitate that growth.
According to Bob Christianson, manager of the De Smet plant, the acquisition will enable the company to expand, employ more people, improve product flow, reduce costs and better serve their customers.
UltiMed is known for its UltiGuard system, which combines needle storage and safe disposal in one package. ?It is also the largest manufacturer of syringes used to treat small animals with diabetes.
Production employees assemble, sterilize, package and prepare the product for shipping.
The company runs both a day and night shift, with opportunities for flexible part-time work. There are presently 57 people employed in the De Smet location.
UltiMed was founded in 1988 and brought operations to De Smet in 2001 under the name Shin-America. They began production in the 15,000 square-foot former Raven’s building in Industrial Park. In 2006, they leased the former CMI building, and eventually bought it and connected the two buildings. This expanded their building to 50,000 square feet.
In November 2013, the plant began another round of renovations that are expected to be completed in February 2015.
The De Smet News